Literature DB >> 15699336

Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface.

Ann-Kristin Mueller1, Nelly Camargo, Karine Kaiser, Cathy Andorfer, Ute Frevert, Kai Matuschewski, Stefan H I Kappe.   

Abstract

Plasmodium parasites of mammals, including the species that cause malaria in humans, infect the liver first and develop there into clinically silent liver stages. Liver stages grow and ultimately produce thousands of first-generation merozoites, which initiate the erythrocytic cycles causing malaria pathology. Here, we present a Plasmodium protein with a critical function for complete liver stage development. UIS4 (up-regulated in infective sporozoites gene 4) is expressed exclusively in infective sporozoites and developing liver stages, where it localizes to the parasitophorous vacuole membrane. Targeted gene disruption of UIS4 in the rodent model malaria parasite Plasmodium berghei generated knockout parasites that progress through the malaria life cycle until after hepatocyte invasion but are severely impaired in further liver stage development. Immunization with UIS4 knockout sporozoites completely protects mice against subsequent infectious WT sporozoite challenge. Genetically attenuated liver stages may thus induce immune responses, which inhibit subsequent infection of the liver with WT parasites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699336      PMCID: PMC548321          DOI: 10.1073/pnas.0408442102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Exoerythrocytic development of malarial parasites.

Authors:  J F Meis; J P Verhave
Journal:  Adv Parasitol       Date:  1988       Impact factor: 3.870

2.  Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi.

Authors:  J C Beier; J R Davis; J A Vaughan; B H Noden; M S Beier
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

3.  Exploring the transcriptome of the malaria sporozoite stage.

Authors:  S H Kappe; M J Gardner; S M Brown; J Ross; K Matuschewski; J M Ribeiro; J H Adams; J Quackenbush; J Cho; D J Carucci; S L Hoffman; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

4.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

5.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

6.  TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites.

Authors:  A A Sultan; V Thathy; U Frevert; K J Robson; A Crisanti; V Nussenzweig; R S Nussenzweig; R Ménard
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

7.  Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage.

Authors:  Kai Matuschewski; Jessica Ross; Stuart M Brown; Karine Kaiser; Victor Nussenzweig; Stefan H I Kappe
Journal:  J Biol Chem       Date:  2002-08-12       Impact factor: 5.157

8.  Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei.

Authors:  L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Imaging movement of malaria parasites during transmission by Anopheles mosquitoes.

Authors:  Friedrich Frischknecht; Patricia Baldacci; Béatrice Martin; Christophe Zimmer; Sabine Thiberge; Jean-Christophe Olivo-Marin; Spencer L Shorte; Robert Ménard
Journal:  Cell Microbiol       Date:  2004-07       Impact factor: 3.715

10.  Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins.

Authors:  Karine Kaiser; Kai Matuschewski; Nelly Camargo; Jessica Ross; Stefan H I Kappe
Journal:  Mol Microbiol       Date:  2004-03       Impact factor: 3.501

View more
  165 in total

1.  Development of the malaria parasite in the skin of the mammalian host.

Authors:  Pascale Gueirard; Joana Tavares; Sabine Thiberge; Florence Bernex; Tomoko Ishino; Genevieve Milon; Blandine Franke-Fayard; Chris J Janse; Robert Ménard; Rogerio Amino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.

Authors:  Bruno Douradinha; Melissa van Dijk; Geert-Jan van Gemert; Shahid M Khan; Chris J Janse; Andy P Waters; Robert W Sauerwein; Adrian Jf Luty; Bruno Silva-Santos; Maria M Mota; Sabrina Epiphanio
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-17

3.  Protein targeting to the parasitophorous vacuole membrane of Plasmodium falciparum.

Authors:  Saliha Eksi; Kim C Williamson
Journal:  Eukaryot Cell       Date:  2011-04-15

Review 4.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

5.  Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.

Authors:  Melissa R van Dijk; Bruno Douradinha; Blandine Franke-Fayard; Volker Heussler; Maaike W van Dooren; Ben van Schaijk; Geert-Jan van Gemert; Robert W Sauerwein; Maria M Mota; Andrew P Waters; Chris J Janse
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

Review 6.  Live attenuated pre-erythrocytic malaria vaccines.

Authors:  Gladys J Keitany; Marissa Vignali; Ruobing Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

8.  A key role for lipoic acid synthesis during Plasmodium liver stage development.

Authors:  Brie Falkard; T R Santha Kumar; Leonie-Sophie Hecht; Krista A Matthews; Philipp P Henrich; Sonia Gulati; Rebecca E Lewis; Micah J Manary; Elizabeth A Winzeler; Photini Sinnis; Sean T Prigge; Volker Heussler; Christina Deschermeier; David Fidock
Journal:  Cell Microbiol       Date:  2013-04-05       Impact factor: 3.715

9.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 10.  Malaria: progress, perils, and prospects for eradication.

Authors:  Brian M Greenwood; David A Fidock; Dennis E Kyle; Stefan H I Kappe; Pedro L Alonso; Frank H Collins; Patrick E Duffy
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.